Dogwood Therapeutics (DWTX) EPS (Basic) (2020 - 2026)
Dogwood Therapeutics (DWTX) posted EPS (Basic) of -$0.34 for Q2 2026, down 127.25% on a QoQ basis from -$0.15 in Q1 2026, and up 83.04% year-over-year from -$0.18 in Q2 2025.
Powered by 
Analysis
Dogwood Therapeutics (DWTX) EPS (Basic) (2020 - 2026) Analysis & Trends
Dogwood Therapeutics has reported EPS (Basic) for 7 years, with the latest figure at -$0.34 in Q2 2026.
- On a quarterly basis, EPS (Basic) rose 83.04% year-over-year to -$0.34 in Q2 2026; TTM through Jun 2026 was -$1.06, a 92.39% increase from a year earlier, with the FY2025 full-year figure at -$7.13, up 42.99% from the prior year.
- EPS (Basic) was -$0.34 for Q2 2026 at Dogwood Therapeutics, down from -$0.15 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.15 in Q1 2026, with the low at -$11.89 in Q1 2022.
- Average EPS (Basic) over 5 years is -$4.13, with a median of -$2.02 recorded in 2024.
- The sharpest annual moves came in 2024 and 2026: EPS (Basic) plunged 445.97% in 2024, then soared 98.24% in 2026.
- Over 5 years, EPS (Basic) stood at -$4.62 in 2022, then jumped by 68.19% to -$1.47 in 2023, then slumped by 445.97% to -$8.02 in 2024, then jumped by 90.53% to -$0.76 in 2025, then surged by 55.52% to -$0.34 in 2026.
- The last three EPS (Basic) figures came in at -$0.34 (Q2 2026), -$0.15 (Q1 2026), and -$0.76 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -0.40 |
| 10 | Dogwood Therapeutics | 65.53 Mn | 65.53 Mn | - | -0.34 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.34 |
| Mar 31, 2026 | -0.15 |
| Dec 31, 2025 | -0.76 |
| Sep 30, 2025 | -8.20 |
| Jun 30, 2025 | -1.99 |
| Mar 31, 2025 | -8.45 |
| Dec 31, 2024 | -8.02 |
| Sep 30, 2024 | -2.05 |
| Jun 30, 2024 | -1.15 |
| Mar 31, 2024 | -1.68 |
| Dec 31, 2023 | -1.47 |
| Sep 30, 2023 | -1.62 |
| Jun 30, 2023 | -1.96 |
| Mar 31, 2023 | -2.07 |
| Dec 31, 2022 | -4.62 |
| Sep 30, 2022 | -7.00 |
| Jun 30, 2022 | -11.01 |
| Mar 31, 2022 | -11.89 |
| Dec 31, 2021 | -13.54 |
| Sep 30, 2021 | -12.33 |